Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 32Adenocarcinoma of Lung 13Adenocarcinoma, Bronchiolo-Alveolar 9Breast Neoplasms 8Neoplasm Metastasis 7Pancreatic Neoplasms 6Neoplasms 6Melanoma 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Endometrial Neoplasms 4Colorectal Neoplasms 4Carcinoma, Ovarian Epithelial 4Urinary Bladder Neoplasms 3Pleural Effusion, Malignant 3Carcinoma, Renal Cell 3Thymoma 2Testicular Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Unknown Primary 2Mouth Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2

Interventions

Taxes 1Paclitaxel 1Lapatinib 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Taxes × Thoracic × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡